Your session is about to expire
← Back to Search
Digital Mental Health Technologies for Pediatric Mental Health (TeACH Trial)
N/A
Recruiting
Research Sponsored by Rush University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of once per year.
Awards & highlights
No Placebo-Only Group
Summary
This trial will use digital mental health technologies to help improve engagement, assessment, detection, treatment, and delivery of services for pediatric mental health, specifically for underserved teens and their families.
Who is the study for?
This trial is for teens aged 13-17 with symptoms of anxiety disorder, who are getting care at certain Rush University Health System and University of Illinois at Chicago Pediatric Primary Care clinics. They must be able to speak and read English. Teens not meeting these criteria cannot participate.
What is being tested?
The study tests the TeACH System, a digital mental health technology designed for pediatric mental health care. It involves collaboration with teens and parents (Phase 1), refining the system with healthcare staff (Phase 2), and evaluating it in a randomized trial within primary care clinics (Phase 3).
What are the potential side effects?
Since this trial focuses on digital technologies rather than medications, traditional side effects like those seen with drugs are not applicable. However, there may be non-medical concerns such as privacy issues or stress related to technology use.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion, an average of once per year.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of once per year.
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Anxiety Understanding: Baseline
Anxiety Understanding: Maintenance
Anxiety Understanding: Post Interaction
+10 moreSecondary study objectives
After-Scenario Questionnaire (ASQ): Maintenance
After-Scenario Questionnaire (ASQ): Post Interaction
Kiddie-Computerized Adaptive Tests (K-CAT) Anxiety Module
Other study objectives
Demographics
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: TeACH System ResourcesExperimental Treatment1 Intervention
Patients who screen positive for anxiety will receive stakeholder-informed feedback and resources (i.e., psychoeducation and mental health recommendations).
Group II: Evidence-based ResourcesActive Control1 Intervention
Patients who screen positive for anxiety will receive a link to a webpage providing psychoeducation about anxiety and possible treatment options.
Find a Location
Who is running the clinical trial?
University of Illinois at ChicagoOTHER
640 Previous Clinical Trials
1,568,408 Total Patients Enrolled
1 Trials studying Mental Health
180 Patients Enrolled for Mental Health
Rush University Medical CenterLead Sponsor
439 Previous Clinical Trials
249,946 Total Patients Enrolled
1 Trials studying Mental Health
35 Patients Enrolled for Mental Health
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I experience symptoms of anxiety.I am between 13 and 17 years old.
Research Study Groups:
This trial has the following groups:- Group 1: Evidence-based Resources
- Group 2: TeACH System Resources
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.